Publication:
Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD.

Loading...
Thumbnail Image

Date

2021-06-23

Authors

Marques, Vanda
Afonso, Marta B
Bierig, Nina
Duarte-Ramos, Filipa
Santos-Laso, Álvaro
Jimenez-Agüero, Raul
Eizaguirre, Emma
Bujanda, Luis
Pareja, Maria J
Luís, Rita

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Background: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease where liver biopsy remains the gold standard for diagnosis. Here we aimed to evaluate the role of circulating adiponectin, leptin, and insulin-like growth factor 1 (IGF-1) levels as non-invasive NAFLD biomarkers and assess their correlation with the metabolome. Materials and Methods: Leptin, adiponectin, and IGF-1 serum levels were measured by ELISA in two independent cohorts of biopsy-proven obese NAFLD patients and healthy-liver controls (discovery: 38 NAFLD, 13 controls; validation: 194 NAFLD, 31 controls) and correlated with clinical data, histology, genetic parameters, and serum metabolomics. Results: In both cohorts, leptin increased in NAFLD vs. controls (discovery: AUROC 0.88; validation: AUROC 0.83; p

Description

MeSH Terms

DeCS Terms

CIE Terms

Keywords

IGF-1, NAFLD, adiponectin, circulating biomarkers, fibrosis, leptin, lipid metabolism

Citation